De novo factor VIII gene intron 22 inversion in a female carrier presents as a somatic mosaicism.
The intron 22 inversion represents the most prevalent factor VIII gene defect in severe hemophilia A, accounting for about 40% of all mutations. It is hypothesized that the inversion mutations occur almost exclusively in germ cells during meiotic cell division by intrachromosomal recombination between 1 of 2 telomeric copies of the Int22h region and its intragenic homologue. The majority of inversion mutations originate in male germ cells, where the lack of bivalent formation may facilitate flipping of the telomeric end of the single X chromosome. This is the first intron 22 inversion that presents as a somatic mosaicism in a female, affecting only about 50% of lymphocyte and fibroblast cells of the proposita. Supposing a post-zygotic de novo mutation as the usual cause of somatic mosaicism, the finding would imply that the intron 22 inversion mutation is not restricted to meiotic cell divisions but can also occur during mitotic cell divisions, either in germ cell precursors or in somatic cells. (Blood. 2000;96:2905-2906)
Oldenburg
J
J
Department of Human Genetics, University of Würzburg, Biozentrum, Würzburg, Germany. j.oldenburg@biozentrum.uni-wuerzberg.de
Rost
S
S
El-Maarri
O
O
Leuer
M
M
Olek
K
K
Müller
C R
CR
Schwaab
R
R
D000328:Adult; D000483:Alleles; D015139:Blotting, Southern; D007446:Chromosome Inversion; D005169:Factor VIII / Q000235:genetics*; D005260:Female; D006467:Hemophilia A / Q000235:genetics*; D006579:Heterozygote; D006801:Humans; D007223:Infant; D007438:Introns / Q000235:genetics*; D008297:Male; D008540:Meiosis; D008938:Mitosis; D009030:Mosaicism / Q000235:genetics*; D009154:Mutation
D005169:Factor VIII